Association between maternal comorbidity and preterm birth by severity and clinical subtype: retrospective cohort

Nathalie Auger1, Thi Uyen Nhi Le, Alison L Park

  • 1Institut National de Santé Publique du Québec, 190, boulevard Crémazie Est, Montréal, Québec, H2P-1E2, Canada. nathalie.auger@inspq.qc.ca

Insights

Maternal comorbidities significantly increase preterm birth (PTB) risk, with specific conditions linked to different PTB subtypes and gestational ages. Addressing reproductive system issues, preeclampsia, and anemia may help prevent spontaneous PTB and preterm premature rupture of membranes (PPROM).

Area of Science:

  • Reproductive Health
  • Perinatal Epidemiology
  • Maternal-Fetal Medicine

Background:

  • Preterm birth (PTB) is a leading cause of infant mortality and morbidity.
  • The association between maternal comorbidities and PTB, considering clinical subtypes and gestational age, is not well understood.

Purpose of the Study:

  • To evaluate the relationship between maternal comorbidities and PTB, categorized by clinical subtype and gestational age.

Main Methods:

  • A retrospective cohort study analyzed 1,329,737 singleton births in Québec, Canada (1989-2006).
  • PTB was classified by clinical subtype (medically indicated, PPROM, spontaneous preterm labor) and gestational age.
  • Polytomous logistic regression was used to estimate odds ratios for PTB subtypes associated with maternal comorbidities.

Main Results:

  • Mothers with comorbidities had higher PTB rates (10.9%) than those without (4.7%).
  • Reproductive system comorbidities were linked to spontaneous PTB; drug dependence and mental disorders were associated with PPROM and spontaneous PTB.
  • Placental abruption, chorioamnionitis, oligohydramnios, structural abnormalities, and cervical incompetence were major contributors to all PTB subtypes, particularly before 32 weeks.

Conclusions:

  • The link between comorbidity and PTB subtypes is gestational age-dependent.
  • Preventing PPROM and spontaneous PTB may require focusing on preeclampsia, anemia, and reproductive system comorbidities.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...